REGU09030 2023 EU Qualified Person (QP) Certification of ATMPs

General Details

Full Title
EU Qualified Person (QP) Certification of ATMPs
Transcript Title
QP Certification of ATMP
Code
REGU09030
Attendance
N/A %
Subject Area
REGU - 0421 Regulatory Affairs
Department
LIFE - Life Sciences
Level
09 - Level 9
Credit
05 - 05 Credits
Duration
Semester
Fee
Start Term
2023 - Full Academic Year 2023-24
End Term
9999 - The End of Time
Author(s)
Mary Butler, Ailish Breen
Programme Membership
SG_SATMP_S09 202300 Postgraduate Certificate in Advanced Therapy Medicinal Products (ATMP) Vector Manufacturing SG_SATMQ_S09 202300 Postgraduate Certificate in Advanced Therapy Medicinal Products (ATMP) Cell Manufacturing SG_SATMP_O09 202300 Postgraduate Diploma in Science in Advanced Therapy Medicinal Products (ATMP) Technology and Manufacturing SG_SATMP_M09 202300 Master of Science in Advanced Therapy Medicinal Products (ATMP) Technology and Manufacturing
Description

This module aims to provide students with an understanding of Qualified Person (QP) certification responsibilities and considerations for Advanced Therapy Medicinal Products (ATMP) and how they differ to traditional pharmaceuticals. In addition, the students will get an overview of the EU and US regulations that apply to ATMPs with a focus on QP aspects.

Learning Outcomes

On completion of this module the learner will/should be able to;

1.

Describe the responsibilities of the QP when certifying ATMP’s

2.

Differentiate between EU and US regulations and guidances in relation to manufacturing and testing of ATMP’s

3.

Evaluate and describe vendor qualification requirements for  ATMP’s

4.

For a given ATMP, determine the importation, distribution and transportation requirements for ATMP’s

5.

Assess ATMP manufacturing and testing challenges and construct solutions

Teaching and Learning Strategies

This Module will be delivered online part time.

A virtual learning environment (e.g. Moodle) will be used as a repository of educational resources and as a means of assessment. Self‑directed, student‑centred, independent learning is a core aspect through completion of module coursework. Some aspects of flipped learning, groupwork, case studies and other active learning methodologies will be incorporated into the module.

Module Assessment Strategies

The assessment approach for this module will be 100% Continuous Assessment with a range of assessment methods employed including some of the following: short-form assessment exams incl. MCQs, project assignments, case studies, essays, oral presentations, viva’s etc. The major element of the assessment may take the form of case studies; these will incorporate real or simulated scenarios, where groups will be tasked to propose and defend solutions.

Repeat Assessments

Repeat assignments of the failed elements will be assigned as per the current Marks and Standards

Indicative Syllabus

  1. Describe the responsibilities of the QP when certifying ATMP’s

Key considerations for the manufacture and Testing of ATMPs

  • Overview of role of QP in the context of ATMPs
  • Process development/validation
  • Analytical method development/validation
  • Importation testing
  • Retain/retention samples

2. Differentiate between EU and US regulations and guidances in relation to manufacturing and testing of ATMP’s

EU GMP requirements for ATMP’s:

  • Overview of EudraLex Volume 4 part IV for ATMPs
  • Overview of EudraLex Volume 4 Annexes 1 and 16 and how they apply to ATMPs
  • EU guidance documents for ATMP’s

US/ICH guidance documents for ATMP’s

  • US guidance documents for ATMP’s
  • ICH guidelines with a focus on ICH Q9, 10, and 11

3. Evaluate and describe vendor qualification requirements for  ATMP’s

Vendor Management requirements for ATMP’s

  • Vendor Qualification requirements
  • Supply Chain map

4. For a given ATMP, determine the importation, distribution and transportation requirements for ATMP’s

Distribution/Transportation of ATMP’s

  • Import/export of ATMP’s to the EU
  • Chain of custody
  • Transportation Qualification
  • Annex 21 requirements
  • Anti-counterfeiting/falsified medicines

5. Assess ATMP manufacturing and testing challenges and construct solutions

Key considerations for QP Certification for ATMP’s

  • Batch record review, QP certification and release
  • MIA/MIA(IMP) updates
  • QP Declarations
  • Risk Assessments
  • Case studies

IMP

  • Parametric Release

Coursework & Assessment Breakdown

Coursework & Continuous Assessment
100 %

Coursework Assessment

Title Type Form Percent Week Learning Outcomes Assessed
1 Assessment Coursework Assessment Open Book Exam 25 % Week 6 1,2
2 Assessment Coursework Assessment Assignment 35 % Week 11 3,4
3 Case study / project Project Group Project 40 % End of Semester 1,2,3,4,5

Online Learning Mode Workload


Type Location Description Hours Frequency Avg Workload
Lecture Online Lecture 2 Weekly 2.00
Independent Learning Not Specified Directed and independent learning 4 Weekly 4.00
Total Online Learning Average Weekly Learner Contact Time 2.00 Hours

Module Resources

Non ISBN Literary Resources
Updated Literary Resources
Journal Resources
URL Resources
Other Resources
  • Eudralex Vol 4 Part IV
  • Eudralex Vol 4, Annex 1
  • Eudralex Vol 4, Annex 13
  • Eudralex Vol 4, Annex 16
Additional Information